TCL1A and breast cancer: Another potential biological pathway involves SNPs that created an estrogen response element near the 3’ end of the T-cell leukemia 1A (TCL1A) gene and was associated with increased musculoskeletal pain in women on adjuvant AI for breast cancer (103).